Literature DB >> 20610412

A pathogenic relationship between a regulator of the actin cytoskeleton and serum response factor.

Angela M Verdoni1, Keaton J Schuster, Brian S Cole, Akihiro Ikeda, Winston W Kao, Sakae Ikeda.   

Abstract

Cell hyperproliferation, inflammation, and angiogenesis are biological processes central to the pathogenesis of corneal disease, as well as other conditions including tumorigenesis and chronic inflammatory disorders. Due to the number of disease conditions that arise as a result of these abnormalities, identifying the molecular mechanisms underlying these processes is critical. The avascular and transparent cornea serves as a good in vivo model to study the pathogenesis of cell hyperproliferation, inflammation, and angiogenesis. Corneal disease 1 (Dstn(corn1)) mice are homozygous for a spontaneous null allele of the destrin (Dstn) gene, which is also known as actin depolymerizing factor (ADF). These mice exhibit abnormalities in the cornea including epithelial cell hyperproliferation, stromal inflammation, and neovascularization. We previously identified that the transcription factor, serum response factor (SRF) and a number of its target genes are upregulated in the cornea of these mice. In this study, we show that conditional ablation of Srf in the corneal epithelium of a diseased Dstn(corn1) cornea results in the rescue of the epithelial cell hyperproliferation, inflammation, and neovascularization phenotypes, delineating an epithelial cell-specific role for SRF in the development of all of these abnormalities. Our study also demonstrates that Dstn is genetically upstream of Srf and defines a new functional role for SRF as the master regulator of a hyperproliferative, inflammatory phenotype accompanied by neovascularization.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20610412      PMCID: PMC2940283          DOI: 10.1534/genetics.110.117309

Source DB:  PubMed          Journal:  Genetics        ISSN: 0016-6731            Impact factor:   4.562


  50 in total

1.  Actin dynamics control SRF activity by regulation of its coactivator MAL.

Authors:  Francesc Miralles; Guido Posern; Alexia-Ileana Zaromytidou; Richard Treisman
Journal:  Cell       Date:  2003-05-02       Impact factor: 41.582

Review 2.  ADF/cofilin and actin dynamics in disease.

Authors:  James R Bamburg; O'Neil P Wiggan
Journal:  Trends Cell Biol       Date:  2002-12       Impact factor: 20.808

3.  Early restriction of peripheral and proximal cell lineages during formation of the lung.

Authors:  Anne-Karina T Perl; Susan E Wert; Andras Nagy; Corrinne G Lobe; Jeffrey A Whitsett
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-26       Impact factor: 11.205

4.  Aberrant actin cytoskeleton leads to accelerated proliferation of corneal epithelial cells in mice deficient for destrin (actin depolymerizing factor).

Authors:  Sakae Ikeda; Leslie A Cunningham; Dawnalyn Boggess; Norman Hawes; Craig D Hobson; John P Sundberg; Jürgen K Naggert; Richard S Smith; Patsy M Nishina
Journal:  Hum Mol Genet       Date:  2003-05-01       Impact factor: 6.150

5.  Improved semiautomatic method for morphometry of angiogenesis and lymphangiogenesis in corneal flatmounts.

Authors:  F Bock; J Onderka; D Hos; F Horn; P Martus; C Cursiefen
Journal:  Exp Eye Res       Date:  2008-08-26       Impact factor: 3.467

6.  Serum response factor promotes re-epithelialization and muscular structure restoration during gastric ulcer healing.

Authors:  Jianyuan Chai; Dolgor Baatar; Andrzej Tarnawski
Journal:  Gastroenterology       Date:  2004-06       Impact factor: 22.682

7.  MR-1 modulates proliferation and migration of human hepatoma HepG2 cells through myosin light chains-2 (MLC2)/focal adhesion kinase (FAK)/Akt signaling pathway.

Authors:  Kaihuan Ren; Haixia Jin; Chunjing Bian; Hongwei He; Xia Liu; Shenghua Zhang; Yiguang Wang; Rong-guang Shao
Journal:  J Biol Chem       Date:  2008-10-23       Impact factor: 5.157

8.  Drosophila pico and its mammalian ortholog lamellipodin activate serum response factor and promote cell proliferation.

Authors:  Ekaterina Lyulcheva; Eleanor Taylor; Magdalene Michael; Anne Vehlow; Shengjiang Tan; Adam Fletcher; Matthias Krause; Daimark Bennett
Journal:  Dev Cell       Date:  2008-11       Impact factor: 12.270

9.  Anti-angiogenesis therapy based on the bone marrow-derived stromal cells genetically engineered to express sFlt-1 in mouse tumor model.

Authors:  M Hu; J-L Yang; H Teng; Y-Q Jia; R Wang; X-W Zhang; Y Wu; Y Luo; X-C Chen; R Zhang; L Tian; X Zhao; Y-Q Wei
Journal:  BMC Cancer       Date:  2008-10-23       Impact factor: 4.430

10.  Myocardin-related transcription factors and SRF are required for cytoskeletal dynamics and experimental metastasis.

Authors:  Souhila Medjkane; Cristina Perez-Sanchez; Cedric Gaggioli; Erik Sahai; Richard Treisman
Journal:  Nat Cell Biol       Date:  2009-02-08       Impact factor: 28.824

View more
  8 in total

Review 1.  Mechanical regulation of chromatin and transcription.

Authors:  Sirio Dupont; Sara A Wickström
Journal:  Nat Rev Genet       Date:  2022-05-23       Impact factor: 59.581

2.  Serum response factor: positive and negative regulation of an epithelial gene expression network in the destrin mutant cornea.

Authors:  Sharolyn V Kawakami-Schulz; Angela M Verdoni; Shannon G Sattler; Erik Jessen; Winston W-Y Kao; Akihiro Ikeda; Sakae Ikeda
Journal:  Physiol Genomics       Date:  2014-02-18       Impact factor: 3.107

3.  Genetic modification of corneal neovascularization in Dstn (corn1) mice.

Authors:  Sharolyn V Kawakami-Schulz; Shannon G Sattler; Anna-Lisa Doebley; Akihiro Ikeda; Sakae Ikeda
Journal:  Mamm Genome       Date:  2013-08-09       Impact factor: 2.957

4.  Ocular surface development and gene expression.

Authors:  Shivalingappa K Swamynathan
Journal:  J Ophthalmol       Date:  2013-02-21       Impact factor: 1.909

5.  Degeneration of the mouse retina upon dysregulated activity of serum response factor.

Authors:  Jenny Sandström; Peter Heiduschka; Susanne C Beck; Ulrike Philippar; Matthias W Seeliger; Ulrich Schraermeyer; Alfred Nordheim
Journal:  Mol Vis       Date:  2011-04-29       Impact factor: 2.367

6.  Differences in corneal phenotypes between destrin mutants are due to allelic difference and modified by genetic background.

Authors:  Sharolyn V Kawakami-Schulz; Angela M Verdoni; Shannon G Sattler; Akihiro Ikeda; Sakae Ikeda
Journal:  Mol Vis       Date:  2012-03-03       Impact factor: 2.367

7.  Identification of functional pathways associated with the conditional ablation of serum response factor in Dstncorn1 mice.

Authors:  Yanan Huo; Xin Xie; Bo Jiang
Journal:  Mol Med Rep       Date:  2016-12-05       Impact factor: 2.952

8.  Fascin1 empowers YAP mechanotransduction and promotes cholangiocarcinoma development.

Authors:  Arianna Pocaterra; Gloria Scattolin; Patrizia Romani; Cindy Ament; Silvia Ribback; Xin Chen; Matthias Evert; Diego F Calvisi; Sirio Dupont
Journal:  Commun Biol       Date:  2021-06-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.